戻る
TYK Medicines, Inc (02410.HK)価格
02410.HK 株価推移チャート
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$13.43
-0.51%
$-0.07
レギュラーマーケット： Jan 19, 11:03:13 HKT
主要データ
前終値
$13.56
始値
$13.5
当日レンジ
$13.26 - $13.57
52週レンジ
$12.1 - $46.1
取引高
587.0K
平均取引高
3.3M
1株当たり利益(TTM)
-0.84
配当利回り
--
時価総額
$5.0B
TYK MEDICINES-Bとは何ですか？
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.